favipiravir - antiviral, one human trial and earlier case reports, known mechanism, not approved in U.S.
lopinavir-ritonavir - antiviral, at least 3 human trials, weak performer, probably does not work unless in huge doses
tocilizumab - one very successful trial, anti-IL6 anti-inflammatory, rescue for severe cases and critical/ARDS
inhaled or IV-pulse steroids - anti-inflammatory
sarilumab - likely about the same as tocilizumab
convalescent plasma - likely helps but only early
potassium - widespread reports of hypokalemia, which this fixes
- nitazoxanide
- niclosamide
- indomethacin
- itraconazole
- isoquercetin
- concentrated echinacea extract
- concentrated elderberry extract (but only shown for other coronaviruses)
- scutellarin
- EGCG (green tea extract)
- glycyrrhizin (licorice extract)
- emetine (castor oil)
- lycorine (various flowers)
These are only a few.
- lactoferrin (bioavailability likely to be limiting)
- high dose garlic extract (no direct testing)
- bromhexine (limited testing)
ARB anti-hypertensives also appear to have protective effects in a retrospective study, but that's all.
I also omitted many drugs with in vitro activity but major systemic toxicity at doses needed to hit IC50.